Abstract
An animal model was used to study the effects of oral treatment with a small molecular selective inhibitor of cysteine proteinases, Z-Phe-Arg-fluoromethylketone (Z-Phe-Arg-FMK) on primary tumour development. Poorly differentiated rapidly growing and moderately differentiated slowly growing human pancreatic tumours were implanted in the neck of nude mice that were orally treated or not with the inhibitor. Growth rates of the tumours were determined during 38 days after implantation. The poorly differentiated tumours were not affected by treatment with the inhibitor. Development of the moderately differentiated tumours was inhibited significantly by Z-Phe-Arg-FMK treatment. Moreover, the amount of stroma was increased and the volume of cancer cells was reduced in the moderately differentiated tumours that had grown in the treated animals. Reduction in size of the tumours was not achieved by reduction in growth rate but in a delay of the onset of growth. It is concluded that cysteine proteinases play a transient role at the start of tumour development only when cancer cells are surrounded by stroma as was the case in the moderately differentiated but not in the poorly differentiated pancreatic tumours. However, this role of cysteine proteinases can easily be taken over by other proteinases. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahmed NK, Martin LA, Watts LM, Palmer J, Thornburg L, Prior J and Esser RE (1992) Peptidyl fluoromethyl ketones as inhibitors of cathepsin B. Biochem Pharmacol 44: 1201–1207
Coen H, Kint H, Kuyper CF, Jonges GN, Dumarey N, Pauwels M, Klöppel G and Roels F (1992) Growth behavior of human pancreatic carcinoma xenografts correlates with nuclear features. Cytometry 13: 775–781
Elliott E and Sloane BF (1996) The cysteine protease cathepsin B in cancer. Perspect Drug Discov Design 6: 12–32
Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA and Stetler-Stevenson WG (1994) Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 145: 1285–1290
Esser RE, Angelo RA, Murphey MD, Watts LM, Thornburg LP, Palmer JT, Talhouk JW and Smith RE (1994) Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthr Rheum 37: 236–247
Everts V, Beertsen W and Tigchelaar-Gutter W (1985) The digestion of phagocytosed collagen is inhibited by the proteinase inhibitors leupeptin and E-64. Collagen Rel Res 5: 315–336
Everts V, Korper W, Niehof A, Jansen DC and Beertsen W (1994) Type VI collagen is phagocytosed by fibroblasts and digested in the lysosomal apparatus: involvement of collagenase, serine proteinases and lysosomal enzymes. Matrix Biol 14: 665–676
Everts V, Korper W, Jansen DC, Steinfort J, Lammerse I, Heera S, Docherty AJP and Beertsen W (1999) Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone. FASEB J 13: 1219–1230
Frederiks WM, Marx F and Myagkaya GL (1989) The ‘nothing dehydrogenase’ reaction and the detection of ischaemic damage. Histochem J 21: 565–573
Griffini P, Smorenburg SM, Verbeek FJ and Van Noorden CJF (1997) Three-dimensional reconstruction of colon carcinoma metastases in liver. J Microsc 187: 12–21
Griffini P, Fehres O, Klieverik L, Vogels IMC, Tigchelaar W, Smorenburg SM and Van Noorden CJF (1998) Dietary Ω-3 polyunsaturated fatty acids promote colon carcinoma metastasis in rat liver. Cancer Res 58: 3312–3319
James J, Bosch KS, Zuyderhoudt FMJ, Houtkooper JM and Van Gool J (1986) Histophotometric estimation of volume density of collagen as an indication of fibrosis in rat liver. Histochemistry 85: 129–133
Johnsen M, Lund LR, Rømer J, Almholt K and Danø K (1998) Cancer invasion and tissue remodeling: common themes in proteolytic matrix degradation. Curr Opin Cell Biol 10: 667–671
Kirschke H, Barrett AJ and Rawlings ND (1995) Cathepsin B (EC 3.4.22.1)In:. Protein Profile, Vol. 2: Lysosomal Cysteine Proteinases, pp. 1588–1591, Academic Press: London
Klöppel G, Otto V, Baisch H and Von Bülow M (1988) Growth, stability and experimental treatment of human tumors after transplantation on thymus aplastic nude mice. Verh Dtsch Ges Path 72: 1–61
Kobayashi H, Schmitt M, Goretzki L, Chucholowski N, Calvete J, Kramer M, Gunzler WA, Janicke F and Graeff H (1991) Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA). J Biol Chem 266: 5147–5152
Mignatti P and Rifkin DB (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 73: 161–195
Noël A, Hajitou A, Hoir CL, Maquoi E, Baramova E, Lewalle J-M, Remacle A, Kebers F, Brown P, Calberg-Bacq C-M and Foidart J-M (1998) Inhibition of stromal matrix metalloproteases: effects on breast-tumor promotion by fibroblasts. Int J Cancer 76: 267–273
Reddy VY, Zhang QY and Weiss SJ (1995) Pericellular mobilization of the tissue-destructive cysteine proteinases, cathepsins B, L, and S, by human monocyte-derived macrophages. Proc Natl Acad Sci USA 92: 3849–3853
Reich R, Thompson EW, Iwamoto Y, Martin GR, Deason JR, Fuller GC and Miskin R (1988) Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells. Cancer Res 48: 3307–3312
Sheahan K, Shuja S and Murnane MJ (1989) Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 49: 3809–3814
Shoobridge MPK (1983) A new principle in polychrome staining: a system of automated staining, complementary to hematoxylin and eosin, and usable as a research tool. Stain Technol 58: 245–258
Sier CFM, Vloedgraven HJM, Ganesh S, Griffioen G, Quax PHA, Verheijen JH, Dooijewaard G, Welvaart K, Van de Velde CJH, Lamers CBHW and Verspaget HW (1994) Inactive urokinase and increased levels of its inhibitor type 1 in colorectal cancer liver metastasis. Gastroenterology 107: 1449–1456
Van Noorden CJF and Everts V (1991) Selective inhibition of cysteine proteinases by Z-Phe-Ala-CH2F suppresses digestion of collagen by fibroblasts and osteoclasts. Biochem Biophys Res Commun 178: 178–184
Van Noorden CJF and Frederiks WM (1992). Enzyme Histochemistry. A Laboratory Manual of Current Methods, BIOS: Oxford
Van Noorden CJF, Smith RE and Rasnick D (1988) Cysteine proteinase activity in arthritic rat knee joints and the effects of a selective systemic inhibitor, Z-Phe-Ala-CH2F. J Rheumatol 15: 1525–1535
Van Noorden CJF, Vogels IMC and Smith RE (1989) Localization and cytophotometric analysis of cathepsin B activity in unfixed and undecalcified cryostat sections of whole rat knee joints. J Histochem Cytochem 37: 617–624
Van Noorden CJF, Jonges GN, Vogels IMC, Hoeben KA, Van Urk B and Everts V (1995) Ectopic mineralized cartilage formation in human undifferentiated pancreatic adenocarcinoma explants grown in nude mice. Calcif Tissue Int 56: 145–153
Van Noorden CJF, Meade-Tollin LC and Bosman FT (1998 a) Metastasis. Am Sci 86: 130–141
Van Noorden CJF, Jonges GN, Van Marle J, Bissell ER, Griffini P, Jans M, Snel J and Smith RE (1998 b) Heterogeneous suppression of experimentally induced colon cancer metastasis in rat liver lobes by inhibition of extracellular cathepsin B. Clin Exp Metast 16: 159–167
Vogels IMC, Van Noorden CJF, Hoeben KA, Korper W, Jonges GN and Everts V (1993) Use of frozen biological material for combined light and electron microscopy. Ultrastruct Pathol 17: 537–546
Weibel ER (1969) Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol 26: 235–302
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Van Noorden, C., Jonges, T., Meade-Tollin, L. et al. In vivo inhibition of cysteine proteinases delays the onset of growth of human pancreatic cancer explants. Br J Cancer 82, 931–936 (2000). https://doi.org/10.1054/bjoc.1999.1021
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.1999.1021